# Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma

> **NCT00846456** · PHASE1,PHASE2 · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 20 (actual)

## Conditions studied

- Glioblastoma
- Brain Tumor

## Interventions

- **BIOLOGICAL:** Dendritic cell vaccine with mRNA from tumor stem cells

## Key facts

- **NCT ID:** NCT00846456
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00846456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00846456, "Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00846456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*